Tianyin Pharmaceutical Co. (TPI) 0.63 $TPI
JCM Applies for Azithromycin API Import Certificate at India
PR Newswire - Tue Sep 09, 8:00AM CDT
Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical medicine, modernized traditional Chinese medicine (TCM), branded generics and active pharmaceutical ingredients (API) further updated the business development at its Jiangchuan Macrolide Facility (JCM) API operation. JCM has initiated the application process for the import certificate to India via India's Central Drugs Standard Control Organization Ministry of Health & Family Welfare. The initiative is triggered by a surge in the orders by API users from India of JCM's Azithromycin API products and intermediates. Further information regarding India's Central Drugs Standard Control Organization could be found at on http://cdsco.nic.in/forms/Default.aspx.
TPI submits Qionglai Facility's dataset under new GMP standards
M2 - Fri Aug 29, 7:17AM CDT
Pharmaceutical company Tianyin Pharmaceutical Co (NYSE Amex:TPI) disclosed on Thursday that it has provided an update on the timeline for the GMP certification regarding its Qionglai Facility (QLF).
TPI Submits Dataset for GMP Inspection at Qionglai Facility (QLF)
PR Newswire - Thu Aug 28, 11:10AM CDT
Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today updates the timeline for the GMP certification regarding the Company's Qionglai Facility (QLF).
Qionglai Facility (QLF) Schedules September for GMP Examination
PR Newswire - Mon Aug 18, 7:30AM CDT
Tianyin Pharmaceutical Co., Inc. (NYSE MKT: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today provided further updates for the GMP certification regarding the Company's Qionglai Facility (QLF).
Testing Runs Progress Updates for TPI's Qionglai Facility
PR Newswire - Mon Aug 04, 2:11AM CDT
Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today provided further updates regarding the Company's Qionglai Facility (QLF).
TPI Targets Early August 2014 to Start Qionglai Facility (QLF) GMP Inspection
PR Newswire - Mon Jul 14, 8:51AM CDT
Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today provided updates regarding the Company's Qionglai Facility (QLF).
TPI Receives GMP for Tablets Formulation in Early July
PR Newswire - Mon Jul 07, 7:53AM CDT
Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical medicine, modernized traditional Chinese medicine (TCM), branded generics and active pharmaceutical ingredients (API), today announced that the Company has received the Good Manufacturing Practice (GMP) certification under certificate number Chuan K0592, valid until December 31, 2015 for its tablets manufacturing division. TPI will start production of the tablets formulation immediately and expect the resumption of full production capacity within 30 days.
TPI Attends CPhI to Facilitate Azithromycin API Export Business
PR Newswire - Sun Jun 29, 7:08PM CDT
Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical medicine, modernized traditional Chinese medicine (TCM), branded generics and active pharmaceutical ingredients (API) attended 2014 China Pharmaceutical International Conference and Exhibit (CPhI China: http://www.cphi-china.cn/) held at Shanghai from June 26th till 28th, 2014 to facilitate the business development of its API division, Jiangchuan Macrolide Facility (JCM).
Health Care Stocks on our Radar -- Research on Novo Nordisk, Tianyin Pharma, Pernix Therapeutics Holdings, and Oculus Innovative Sciences
PR Newswire - Wed Mar 26, 12:10PM CDT
On Tuesday, March 25, 2014, the NASDAQ Composite finished at 4,234.27, up 0.19%. The Dow Jones Industrial Average closed the session at 16,367.88, up 0.56% and the S&P 500 ended the day at 1,865.62, higher by 0.44%. The gains were broad based with nine out of ten sectors ending the session in positive. The S&P 500 Health Care Sector Index finished the day at 671.69, up 0.83%, and the same has gained 5.27% in the previous three months. Investor-Edge has initiated coverage on the following equities: Novo Nordisk A/S (NYSE: NVO), Tianyin Pharmaceutical Co. Inc. (NYSE MKT: TPI), Pernix Therapeutics Holdings (NASDAQ: PTX) and Oculus Innovative Sciences Inc. (NASDAQ: OCLS). Free technical research on NVO, TPI, PTX and OCLS can be downloaded upon signing up at:
TPI Annual Meeting of Shareholders Announcement
PR Newswire - Wed Mar 26, 12:36AM CDT
Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced the time and location for its 2013 Annual Meeting of Shareholders.
3 Stocks Under $10 Making Big Moves
at The Street - Fri Mar 21, 5:00AM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
TPI Reports Second Quarter Fiscal Year 2014 Financial Results
PR Newswire - Thu Feb 13, 11:27PM CST
Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the second quarter fiscal year 2014.
TPI to Host Second Quarter Fiscal Year 2014 Earnings Conference Call on Friday, February 14, 2014 at 9:00 a.m. ET
PR Newswire - Sun Feb 09, 12:56PM CST
Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), today announced that the earnings conference call for the second quarter of fiscal year 2014 ended December 31, 2013 to be held at 9:00 a.m. ET on Friday, February 14th, 2014.
Ubiquiti inks distribution agreement with Ingram Micro
M2 - Thu Jan 16, 8:22AM CST
Ubiquiti Networks, Inc. (NASDAQ: UBNT) said it has announced a US distribution agreement with Ingram Micro Inc. (NYSE: IM).
TPI to Host Fiscal Year 2013 Earnings Conference Call on Friday, September 27th, 2013 at 9 a.m. ET
PR Newswire - Thu Sep 19, 4:00AM CDT
Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), today announced that the earnings conference call for the fiscal year 2013 ending June 30, 2013 to be held at 9:00 a.m. ET on Friday, September 27th, 2013.
TPI Facility Received Official GMP Certificate
PR Newswire - Thu Sep 12, 9:32AM CDT
Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today announced that the Company has received the Official Certificate of GMP for both of its pre-extraction plant and formulate facilities.
Penske completes $200M truck distributor deal
AP - Fri Aug 30, 9:48AM CDT
BLOOMFIELD HILLS, Mich. (AP) — Penske Automotive Group Inc. said Friday that it has completed its acquisition of a business that distributes trucks, spare parts and other services in Australia, New Zealand and in parts of Southeast Asia.
Tianyin Pharmaceutical Co Inc wins CFDA renewal status for TPI manufacturing facility in Longquan County
M2 - Fri Aug 16, 8:18AM CDT
Pharmaceutical company Tianyin Pharmaceutical Co Inc (NYSE Amex:TPI) revealed on Thursday that its its manufacturing facility has received GMP renewal status.
TPI Facility Received GMP Renewal by CFDA
PR Newswire - Thu Aug 15, 11:59AM CDT
Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today provided the updates regarding TPI's manufacturing (pharmaceutical formulation) facility.
JCM Applies for Azithromycin API Import Certificate at India
PR Newswire - Tue Sep 09, 8:00AM CDT
Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical medicine, modernized traditional Chinese medicine (TCM), branded generics and active pharmaceutical ingredients (API) further updated the business development at its Jiangchuan Macrolide Facility (JCM) API operation. JCM has initiated the application process for the import certificate to India via India's Central Drugs Standard Control Organization Ministry of Health & Family Welfare. The initiative is triggered by a surge in the orders by API users from India of JCM's Azithromycin API products and intermediates. Further information regarding India's Central Drugs Standard Control Organization could be found at on http://cdsco.nic.in/forms/Default.aspx.
TPI submits Qionglai Facility's dataset under new GMP standards
M2 - Fri Aug 29, 7:17AM CDT
Pharmaceutical company Tianyin Pharmaceutical Co (NYSE Amex:TPI) disclosed on Thursday that it has provided an update on the timeline for the GMP certification regarding its Qionglai Facility (QLF).
TPI Submits Dataset for GMP Inspection at Qionglai Facility (QLF)
PR Newswire - Thu Aug 28, 11:10AM CDT
Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today updates the timeline for the GMP certification regarding the Company's Qionglai Facility (QLF).
Qionglai Facility (QLF) Schedules September for GMP Examination
PR Newswire - Mon Aug 18, 7:30AM CDT
Tianyin Pharmaceutical Co., Inc. (NYSE MKT: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today provided further updates for the GMP certification regarding the Company's Qionglai Facility (QLF).
Testing Runs Progress Updates for TPI's Qionglai Facility
PR Newswire - Mon Aug 04, 2:11AM CDT
Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today provided further updates regarding the Company's Qionglai Facility (QLF).
TPI Targets Early August 2014 to Start Qionglai Facility (QLF) GMP Inspection
PR Newswire - Mon Jul 14, 8:51AM CDT
Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today provided updates regarding the Company's Qionglai Facility (QLF).
TPI Receives GMP for Tablets Formulation in Early July
PR Newswire - Mon Jul 07, 7:53AM CDT
Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical medicine, modernized traditional Chinese medicine (TCM), branded generics and active pharmaceutical ingredients (API), today announced that the Company has received the Good Manufacturing Practice (GMP) certification under certificate number Chuan K0592, valid until December 31, 2015 for its tablets manufacturing division. TPI will start production of the tablets formulation immediately and expect the resumption of full production capacity within 30 days.
TPI Attends CPhI to Facilitate Azithromycin API Export Business
PR Newswire - Sun Jun 29, 7:08PM CDT
Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical medicine, modernized traditional Chinese medicine (TCM), branded generics and active pharmaceutical ingredients (API) attended 2014 China Pharmaceutical International Conference and Exhibit (CPhI China: http://www.cphi-china.cn/) held at Shanghai from June 26th till 28th, 2014 to facilitate the business development of its API division, Jiangchuan Macrolide Facility (JCM).
Health Care Stocks on our Radar -- Research on Novo Nordisk, Tianyin Pharma, Pernix Therapeutics Holdings, and Oculus Innovative Sciences
PR Newswire - Wed Mar 26, 12:10PM CDT
On Tuesday, March 25, 2014, the NASDAQ Composite finished at 4,234.27, up 0.19%. The Dow Jones Industrial Average closed the session at 16,367.88, up 0.56% and the S&P 500 ended the day at 1,865.62, higher by 0.44%. The gains were broad based with nine out of ten sectors ending the session in positive. The S&P 500 Health Care Sector Index finished the day at 671.69, up 0.83%, and the same has gained 5.27% in the previous three months. Investor-Edge has initiated coverage on the following equities: Novo Nordisk A/S (NYSE: NVO), Tianyin Pharmaceutical Co. Inc. (NYSE MKT: TPI), Pernix Therapeutics Holdings (NASDAQ: PTX) and Oculus Innovative Sciences Inc. (NASDAQ: OCLS). Free technical research on NVO, TPI, PTX and OCLS can be downloaded upon signing up at:
TPI Annual Meeting of Shareholders Announcement
PR Newswire - Wed Mar 26, 12:36AM CDT
Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced the time and location for its 2013 Annual Meeting of Shareholders.
3 Stocks Under $10 Making Big Moves
at The Street - Fri Mar 21, 5:00AM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
TPI Reports Second Quarter Fiscal Year 2014 Financial Results
PR Newswire - Thu Feb 13, 11:27PM CST
Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the second quarter fiscal year 2014.
TPI to Host Second Quarter Fiscal Year 2014 Earnings Conference Call on Friday, February 14, 2014 at 9:00 a.m. ET
PR Newswire - Sun Feb 09, 12:56PM CST
Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), today announced that the earnings conference call for the second quarter of fiscal year 2014 ended December 31, 2013 to be held at 9:00 a.m. ET on Friday, February 14th, 2014.
Ubiquiti inks distribution agreement with Ingram Micro
M2 - Thu Jan 16, 8:22AM CST
Ubiquiti Networks, Inc. (NASDAQ: UBNT) said it has announced a US distribution agreement with Ingram Micro Inc. (NYSE: IM).
TPI to Host Fiscal Year 2013 Earnings Conference Call on Friday, September 27th, 2013 at 9 a.m. ET
PR Newswire - Thu Sep 19, 4:00AM CDT
Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), today announced that the earnings conference call for the fiscal year 2013 ending June 30, 2013 to be held at 9:00 a.m. ET on Friday, September 27th, 2013.
TPI Facility Received Official GMP Certificate
PR Newswire - Thu Sep 12, 9:32AM CDT
Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today announced that the Company has received the Official Certificate of GMP for both of its pre-extraction plant and formulate facilities.
Penske completes $200M truck distributor deal
AP - Fri Aug 30, 9:48AM CDT
BLOOMFIELD HILLS, Mich. (AP) — Penske Automotive Group Inc. said Friday that it has completed its acquisition of a business that distributes trucks, spare parts and other services in Australia, New Zealand and in parts of Southeast Asia.
Tianyin Pharmaceutical Co Inc wins CFDA renewal status for TPI manufacturing facility in Longquan County
M2 - Fri Aug 16, 8:18AM CDT
Pharmaceutical company Tianyin Pharmaceutical Co Inc (NYSE Amex:TPI) revealed on Thursday that its its manufacturing facility has received GMP renewal status.
TPI Facility Received GMP Renewal by CFDA
PR Newswire - Thu Aug 15, 11:59AM CDT
Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today provided the updates regarding TPI's manufacturing (pharmaceutical formulation) facility.
